QbD Group
    On Demand Webinar

    Nitrosamine Risk Assessment: Adapting to the Latest Regulatory Expectations

    Manage the risk of nitrosamines in the pharmaceutical industry. Watch our webinar on demand and learn about regulation and risk analysis from experts.

    On Demand
    60 min
    Toxicology · Pharma
    English

    Proactively identify and manage nitrosamine risks

    Nitrosamine impurities have become a critical and ongoing challenge for the pharmaceutical industry. Regulatory expectations continue to evolve, acceptable exposure limits(AELs)are being reassessed based on evolving toxicological evidence.

    In this webinar, our experts will explain why nitrosamines should remain a priority for pharmaceutical organizations and how the regulatory framework is shaping current and future compliance requirements.

    You will gain clear insight into the data and inputs needed to perform an effective nitrosamine risk assessment (NRA). We will also explore the critical factors that influence nitrosamine formation and how to interpret assessment outcomes to define appropriate actions.

    The session concludes with practical case studies and mitigation strategies, helping you translate regulatory and toxicological concepts into actionable steps for risk minimization.

    What you'll learn

    • Understand what nitrosamine impurities are and why they pose a critical risk to pharmaceutical products.
    • Explore the regulatory landscape, including past developments, current expectations, and upcoming trends.
    • Identify the key data and inputs required for an effective nitrosamine risk assessment.
    • Evaluate critical risk factors and interpret assessment outcomes to support decision-making.
    • Discover practical case studies illustrating strategies to prevent and mitigate nitrosamine formation.

    Learn from the best

    Speakers

    Our speakers bring hands-on experience from toxicology, regulatory compliance, and pharmaceutical development. They will translate complex scientific and regulatory requirements into practical guidance that you can apply in your daily work.

    Pablo Palomar

    Pablo Palomar

    Toxicology Consultant

    Pabloholds a degree in Chemistry and a Master’s degree in Organic Chemistry from the Autonomous University of Madrid (UAM). He currently works as a Toxicology Consultant at QbD Group, with a strong focus on nitrosamine-related regulatory requirements. With over five years of experience in organic synthesis and drug development, he has worked in multiple research laboratories and developed hands-on expertise in a wide range of analytical techniques.
    Natalia Herrera

    Natalia Herrera

    Global Toxicology Liaison

    She holds a PhD in Pharmacy from the University of Medical Sciences of Costa Rica and a Master’s degree in Drug Research, Development and Innovation from the University of Navarra. With a strong background in business development, she previously worked at a preclinical CRO, where she played a key role in driving growth and establishing strategic partnerships. Her professional experience also includes roles as a Medical Sales Representative at several companies, including Abbott. In addition, she has gained valuable experience in quality assurance through her work at Pfizer and other pharmaceutical manufacturing sites, ensuring compliance with industry standards.

    Register here

    Is this for you?

    Who should attend?

    Learn from our experts

    Quality Assurance(QA) and Quality Control (QC) professionals are responsible for ensuring product compliance

    Regulatory Affairs(RA) professionals involved in regulatory strategy, submissions, and interactions with regulatory authorities

    CMC, manufacturing, and technical operations teams supporting nitrosamine risk assessments and mitigation strategies

    Technology Transfer professionals involved in process and product knowledge transfer across development and manufacturing stages

    Formulation and Pharmaceutical Development (R&D) teams involved in product and process design with potential impact on nitrosamine risk

    Keep watching

    More webinars

    AI in Life Sciences: Session 2, Your Questions Answered On Demand Webinar

    AI in Life Sciences: Session 2, Your Questions Answered

    Software Solutions & ServicesMar 31, 2026

    Adopting AI in life sciences holds enormous potential, but navigating GxP requirements adds real complexity. In this joint session, QbD Group and delaware walk you through how to deploy AI that is trustworthy, validated, and inspection-ready, covering data governance, explainability, and lifecycle management. Building on the first session, this edition dedicates more time to answering your questions, addressing the topics raised by the audience in Session 1, and opening the floor for live debate and discussion.

    Watch now

    Get Expert Toxicology Assessments

    QbD Group offers a set of Toxicology services, for your processes, applications, and equipment. We are EUROTOX certified and are members of AETOX.

    Toxicology services

    We use cookies to enhance your experience

    We use essential cookies for site functionality and optional analytics cookies to improve our services. Read our Privacy Policy and Cookie Policy.